Scholars Central

Conference abstractPublished 24 Jun 2014

Bone marrow-derived autologous mesenchymal stem cells for therapy of type 2 diabetes mellitus patients’ tertiary failure

Authors: Purwati Armand, Ari Sutjahjo, Sony Wibisono, Fedik A R, Askandar T J, Anas P, Eric H, Helen S

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

D iabetes Mellitus (DM) is a group of metabolic diseases with hyperglycemic characteristic that occurs due to abnormal insulin secretion, insulin resistance or both. Insulin is a hormone consisting of a series of amino acids produced by the beta cells of the pancreas gland. Various kinds therapies of DM, whether it is preventive, pharmacological and life-style changes, have been attempted for managing diabetes, but the prevalence is higher and higher with high mortality and morbidity as well. Therefore, it necessitates the provision of alternative therapies in the management of DM by using Mesenchymal Stem Cells (MSCs) Method : Twelve Patients with inclusion criteria of type 2 diabetic with tertiary failure of treatment were given autologous MSCs derived from bone marrow stem cells. MSCs were inserted through catheterization of pancreatic dorsalis artery or gastroduodenal artery, and then the levels of fasting blood sugar was measured, 2 hours postprandial blood sugar, insulin, C peptide, HbA 1C, HOMA- R, HOMA- B pre and post stem cell transplantation in the first, second and third months. Result : Evaluation in patients receiving stem cell therapy in combination with insulin showed a decrease in fasting glucose levels and glucose levels 2 hours after meals in the first month, and increased levels of C peptide in the second month. Examination of the first month also showed decreased levels of HOMA- IR, which is indicative of insulin resistance, and increased HOMA B. Conclusion : Bone-marrow derived MSCs can improve pancreatic function and decrease insulin resistance in diabetic patients with tertiary failure treatment.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Purwati Armand”
  • BylineArticles whose byline prints “Ari Sutjahjo”
  • BylineArticles whose byline prints “Sony Wibisono”
  • BylineArticles whose byline prints “Fedik A R”
  • BylineArticles whose byline prints “Askandar T J”
  • BylineArticles whose byline prints “Anas P”
  • BylineArticles whose byline prints “Eric H”
  • BylineArticles whose byline prints “Helen S”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels